Lipotrol
97/100
This product looks safe
- Niacin: 375mg is 10.7× the Tolerable Upper Intake Level (35mg)
- 38% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 375mg is 10.7× the Tolerable Upper Intake Level (35mg)
Label Data
2 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
38%
Evidence Coverage
Supplement Facts — Evidence Check
Phytosterol Complex
150 mg
375 mg
⚠️ Exceeds Tolerable Upper Intake Level by 10.7× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Guar Gum
50 mg
Lecithin
450 mg
📊 Market median: 600.0mg (79 products)
📚 24 studies (Tier A: 0, B: 6)
68 mg
✅ Within RDA (0.1× RDA of 550 mg)
📚 36 studies (Tier A: 1, B: 7)
75 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
500 mcg
📊 Market median: 200.0mg (136 products)
📚 3 studies — no high-quality reviews
Papain
50 mg
50 mg
📊 Market median: 500.0mg (283 products)
📚 173 studies (Tier A: 0, B: 62)
Hesperidin
13 mg
5 mg
📊 Market median: 500.0mg (19 products)
Synergistically Balanced Proprietary Blend
150 mg
Other Ingredients
Cellulose
Calcium
Vegetable Stearate
Silica
Label Claims — Verification
❓
No Claim
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
🧪 Formulation Notes
A phytospiritually formulated lab tested product
Additional Information
Health Yourself
Product Details
DSLD Entry Date
2021-01-22
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Purity Products
DSLD ID
243814
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100